About 100 reports

  • MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET IN APAC
  • MUSCULOSKELETAL DISORDERS THERAPEUTICS MARKET IN AMERICAS
  • Musculoskeletal Disorder
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly & Co.

Musculoskeletal Disorders Drugs Global Market Report 2018 ##.

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • World
  • Musculoskeletal Drugs Market Forecast Growth
  • Musculoskeletal Drugs Market Historic Growth
  • Musculoskeletal Disorder
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • 6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS
  • Musculoskeletal Disorder
  • Specialty Hospital
  • World
  • Market Segment
  • Dynatronics Corporation
  • 7.1 BIBLIOGRAPHY

Epidemiology of rheumatic musculoskeletal disorders in the developing world.

  • Musculoskeletal Disorder
  • Forecast
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlobalData's company
  • Osteoporosis Therapeutics Market, Global, All Pipeline Products, Discovery,
  • Musculoskeletal Disorder
  • World
  • Market Size
  • Amgen Inc.
  • Merck & Co., Inc.
  • INDIA KNEE OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS PATIENT
  • MARKET OVERVIEW: INDIA

In India, about ##% of the overall population suffers from ailments related to musculoskeletal disorders (MSD).

  • Musculoskeletal Disorder
  • Asia
  • Smith & Nephew Plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

Molecule description In June 2010, BioTime reported that it had formed a new subsidiary, OrthoCyte, to develop novel therapeutics based on stem cell technology for the treatment of injuries and disorders affecting the musculoskeletal system, including therapeutics that would regene

  • Musculoskeletal Disorder
  • United States
  • Asterias Biotherapeutics, Inc.
  • BioTime, Inc.
  • OrthoCyte Corporation

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women' s health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology.

  • Musculoskeletal Disorder
  • China
  • Demand
  • Novartis AG
  • Pfizer Inc.
  • PIPELINE MOLECULES: LESS LIKELY CANDIDATES FOR AUTOINJECTORS
  • Rheumatoid arthritis
  • Injectable Delivery
  • Musculoskeletal Disorder
  • Neurological Disorder
  • Demand
  • Market Size

Its R& D is focused on the following six therapeutic areas: endocrine diseases, cancer, autoimmune diseases, neurological disorders, musculoskeletal disorders, and cardiovascular diseases.

  • Musculoskeletal Disorder
  • Amgen Inc.
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novartis AG
  • 12.1 INTRODUCTION

IN INDIA, ##% OF THE OVERALL POPULATION SUFFERS FROM AILMENTS RELATED TO MUSCULOSKELETAL DISORDERS (MSD).

  • Musculoskeletal Disorder
  • Asia
  • Europe
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.

Wyeth has a long history of pioneering developments in pharmaceuticals and biotechnology, with leading products in the areas of women' s health care, neuroscience, musculoskeletal disorders, vaccines and infectious disease, hemophilia, and oncology.

  • Musculoskeletal Disorder
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Vendor landscape

FROBEN IS INDICATED TO TREAT OSTEOARTHRITIS, RHEUMATOID DISEASE, ANKYLOSING SPONDYLITIS, MUSCULOSKELETAL DISORDERS, AND TRAUMA, INCLUDING PERIARTHRITIS, BURSITIS, FROZEN SHOULDER, TENDINITIS, LOW BACK PAIN, TENOSYNOVITIS, SPRAINS, AND STRAINS.

  • Musculoskeletal Disorder
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • 4.1 BIBLIOGRAPHY

BMC Musculoskeletal Disorders; ##(##): ##.

  • Arthritis
  • Musculoskeletal Disorder
  • Japan
  • United States
  • Forecast
  • REFERENCES

Prevalence and impact of musculoskeletal disorders of the upper limb in the general population.

  • Arthritis
  • Musculoskeletal Disorder
  • Europe
  • United States
  • Forecast
  • REFERENCES

Prevalence and impact of musculoskeletal disorders of the upper limb in the general population.

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Europe
  • United States
  • 12.1 INTRODUCTION

IN INDIA, ## PERCENT OF THE OVERALL POPULATION SUFFERS FROM AILMENTS RELATED TO MUSCULOSKELETAL DISORDERS (MSD).

  • Musculoskeletal Disorder
  • Asia
  • Europe
  • Forecast
  • Zimmer Biomet Holdings, Inc.

The data focuses on (##) arthropathies: e. g. infectious arthropathies; inflammatory polyarthropathies; arthrosis; systemic connective tissue disorders, (##) dorsopathies: e. g. deforming dorsopathies; spondylopathies, (##) soft tissue disorders: e. g. disorders of muscles;

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • Germany
  • REFERENCES

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • Europe
  • 11.1 BIBLIOGRAPHY

MUSCULOSKELETAL DISORDERS; ##(##): ##.

  • Musculoskeletal Disorder
  • Japan
  • United States
  • Ampio Pharmaceuticals, Inc.
  • Pfizer Inc.

SUMMARY: - Musculoskeletal Disorders Pipeline by Indication - Musculoskeletal Disorders Pipeline by Clinical Trial Phase - Musculoskeletal Disorders Pipeline by Drug Mechanism Classes - Musculoskeletal Disorders Pipeline by Comp

  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

  • Chronic Disease
  • Epidemiology
  • Musculoskeletal Disorder
  • Europe
  • Forecast
  • 8.2 MUSCULOSKELETAL DISORDERS
  • MUSCULOSKELETAL DISORDERS COMMANDS THE LARGEST SHARE OF THE
  • Musculoskeletal Disorder
  • Stem Cell Therapy
  • World
  • Market Size
  • MediPost Co., Ltd.
  • 8.2 ORTHOPEDIC & MUSCULOSKELETAL DISORDERS
  • ORTHOPEDIC & MUSCULOSKELETAL DISORDERS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • Molecular Biology
  • Musculoskeletal Disorder
  • Tissue Engineering
  • World
  • Acelity L.P. Inc.
  • PROPORTION OF DERMATOMYOSITIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, E7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF DERMATOMYOSITIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • Autoimmune Disease
  • Musculoskeletal Disorder
  • Neurological Disorder
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF DEGENERATIVE SPONDYLOLISTHESIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • PROPORTION OF DEGENERATIVE SPONDYLOLISTHESIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Hospital
  • Musculoskeletal Disorder
  • Therapy
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF FASCIITIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • PROPORTION OF FASCIITIS TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • SMALL MOLECULE TO INHIBIT BMP FOR CARDIOVASCULAR, CNS, ONCOLOGY AND MUSCULOSKELETAL DISORDERS - DRUG PROFILE
  • FIBRODYSPLASIA OSSIFICANS PROGRESSIVA (MYOSITIS OSSIFICANS PROGRESSIVA) - PIPELINE BY LA JOLLA PHARMACEUTICAL COMPANY, H1 2017
  • Musculoskeletal Disorder
  • United States
  • World
  • Product Initiative
  • Clementia Pharmaceuticals Inc.
  • PROPORTION OF FROZEN SHOULDER SYNDROME TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS, G7 COUNTRIES (%), 2017*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF FROZEN SHOULDER SYNDROME TO MUSCULOSKELETAL DISORDERS CLINICAL TRIALS
  • Clinical Trial
  • Drug Discovery And Development
  • Musculoskeletal Disorder
  • World
  • Product Initiative